Cheyne Capital Management (UK) LLP - AURINIA PHARMACEUTICALS INC ownership

AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 16 filers reported holding AURINIA PHARMACEUTICALS INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Cheyne Capital Management (UK) LLP ownership history of AURINIA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2015$257,000
-6.2%
90,0000.0%0.12%
+36.0%
Q2 2015$274,000
-31.7%
90,0000.0%0.09%
-8.2%
Q1 2015$401,000
+24.1%
90,0000.0%0.10%
+14.1%
Q4 2014$323,000
-6.9%
90,000
-15.7%
0.08%
-31.5%
Q3 2014$347,000106,8050.12%
Other shareholders
AURINIA PHARMACEUTICALS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Blackcrane Capital, LLC 111,608$2,470,0003.15%
ACT CAPITAL MANAGEMENT, LLC 180,000$3,983,0002.06%
IRONWOOD INVESTMENT MANAGEMENT LLC 167,889$3,715,0001.92%
DG Capital Management, LLC 402,200$8,901,0001.81%
NEA Management Company, LLC 5,172,683$114,471,0001.36%
KESTRA PRIVATE WEALTH SERVICES, LLC 801,100$17,728,0000.99%
Altium Capital Management LP 144,000$3,187,0000.84%
HighMark Wealth Management LLC 50,569$1,119,0000.82%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 123,500$2,724,0000.66%
SEVEN EIGHT CAPITAL, LP 288,840$6,392,0000.62%
View complete list of AURINIA PHARMACEUTICALS INC shareholders